• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体在乳腺癌中作用的分子机制:对细胞增殖和干细胞调控的深入了解。

Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.

机构信息

Instituto de Biología y Medicina Experimental (IBYME), CONICET, Vuelta de Obligado 2490, Buenos Aires C1428ADN, Argentina.

Instituto de Biología y Medicina Experimental (IBYME), CONICET, Vuelta de Obligado 2490, Buenos Aires C1428ADN, Argentina.

出版信息

Steroids. 2019 Dec;152:108503. doi: 10.1016/j.steroids.2019.108503. Epub 2019 Sep 25.

DOI:10.1016/j.steroids.2019.108503
PMID:31562879
Abstract

The ovarian steroid hormone progesterone and its nuclear receptor, the Progesterone Receptor (PR), play an essential role in the regulation of cell proliferation and differentiation in the mammary gland. In addition, experimental and clinical evidence demonstrate their critical role in controlling mammary gland tumorigenesis and breast cancer development. When bound to its ligand, the main action of PR is as a transcription factor, which regulates the expression of target genes networks. PR also activates signal transduction pathways through a rapid or non-genomic mechanism in breast cancer cells, an event that is fully integrated with its genomic effects. This review summarizes the molecular mechanisms of the ligand-activated PR actions that drive epithelial cell proliferation and the regulation of the stem cell population in the normal breast and in breast cancer.

摘要

卵巢甾体激素孕激素及其核受体孕激素受体(PR)在乳腺细胞增殖和分化的调节中发挥着重要作用。此外,实验和临床证据表明它们在控制乳腺肿瘤发生和乳腺癌发展中具有关键作用。当与配体结合时,PR 的主要作用是作为转录因子,调节靶基因网络的表达。PR 还通过乳腺癌细胞中的快速或非基因组机制激活信号转导途径,这一事件与它的基因组效应完全整合。这篇综述总结了配体激活的 PR 作用的分子机制,这些作用驱动着正常乳腺和乳腺癌中上皮细胞的增殖和干细胞群体的调节。

相似文献

1
Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.孕激素受体在乳腺癌中作用的分子机制:对细胞增殖和干细胞调控的深入了解。
Steroids. 2019 Dec;152:108503. doi: 10.1016/j.steroids.2019.108503. Epub 2019 Sep 25.
2
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.翻译后修饰的孕激素受体指导乳腺癌干细胞相关基因程序的配体特异性表达。
J Hematol Oncol. 2017 Apr 17;10(1):89. doi: 10.1186/s13045-017-0462-7.
3
Progesterone Receptor Signaling Mechanisms.孕激素受体信号传导机制
J Mol Biol. 2016 Sep 25;428(19):3831-49. doi: 10.1016/j.jmb.2016.06.020. Epub 2016 Jul 2.
4
Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.孕激素受体(PR)介导信号转导和转录激活因子(STAT)的作用:乳腺癌模型中PR与催乳素受体信号转导的相互作用
J Steroid Biochem Mol Biol. 2018 Feb;176:88-93. doi: 10.1016/j.jsbmb.2017.04.011. Epub 2017 Apr 23.
5
Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.重新审视孕激素受体(PR)在乳腺癌中的作用:对PR抑制功能的见解。
Steroids. 2018 May;133:75-81. doi: 10.1016/j.steroids.2017.12.015. Epub 2018 Jan 6.
6
Steroid hormones, steroid receptors, and breast cancer stem cells.类固醇激素、类固醇受体与乳腺癌干细胞。
J Mammary Gland Biol Neoplasia. 2015 Jun;20(1-2):39-50. doi: 10.1007/s10911-015-9340-5. Epub 2015 Aug 12.
7
The biology of progesterone receptor in the normal mammary gland and in breast cancer.孕激素受体在正常乳腺和乳腺癌中的生物学特性。
Mol Cell Endocrinol. 2012 Jun 24;357(1-2):4-17. doi: 10.1016/j.mce.2011.10.030. Epub 2011 Dec 13.
8
The molecular basis of progesterone receptor action in breast carcinogenesis.孕激素受体在乳腺癌发生中作用的分子基础。
Horm Mol Biol Clin Investig. 2012 Apr;9(2):105-17. doi: 10.1515/hmbci-2011-0129.
9
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.人乳腺癌细胞中两种孕酮受体亚型的差异基因调控
J Biol Chem. 2002 Feb 15;277(7):5209-18. doi: 10.1074/jbc.M110090200. Epub 2001 Nov 20.
10
TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.TReP-132是一种新型的孕酮受体共激活因子,孕酮抑制乳腺癌细胞生长并增强分化作用时需要该因子。
Mol Cell Biol. 2006 Oct;26(20):7632-44. doi: 10.1128/MCB.00326-06.

引用本文的文献

1
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer.雌激素受体阳性/孕激素受体阴性乳腺癌的研究进展
Transl Oncol. 2025 Jun;56:102387. doi: 10.1016/j.tranon.2025.102387. Epub 2025 Apr 14.
2
Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma.新辅助治疗乳腺癌的个性化多因素风险评估
Breast Cancer Res Treat. 2025 Apr;210(2):463-475. doi: 10.1007/s10549-024-07584-4. Epub 2024 Dec 30.
3
Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer.
孕激素受体(PR)的位点特异性O-连接N-乙酰葡糖胺化支持PR对乳腺癌中干扰素刺激基因(ISG)的抑制及肿瘤生长。
J Biol Chem. 2024 Nov;300(11):107886. doi: 10.1016/j.jbc.2024.107886. Epub 2024 Oct 11.
4
Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden.敲除 CD73 可通过重编程脂质代谢来延迟 HR 阴性乳腺癌的发病,并与增加肿瘤突变负担有关。
Mol Metab. 2024 Nov;89:102035. doi: 10.1016/j.molmet.2024.102035. Epub 2024 Sep 18.
5
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.克服早期乳腺癌预防试验中的挑战:巴多昔芬和结合雌激素与安慰剂对照。
Contemp Clin Trials. 2024 Nov;146:107697. doi: 10.1016/j.cct.2024.107697. Epub 2024 Sep 17.
6
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol.曲妥珠单抗对BT474三阳性乳腺癌细胞活力的抑制作用被孕酮和雌二醇的联合使用所逆转。
Oncol Lett. 2023 Nov 15;27(1):19. doi: 10.3892/ol.2023.14152. eCollection 2024 Jan.
7
Biomarkers in Breast Cancer: An Old Story with a New End.乳腺癌生物标志物:旧故事的新结局。
Genes (Basel). 2023 Jun 28;14(7):1364. doi: 10.3390/genes14071364.
8
Endocrine-Disrupting Chemicals and Disease Endpoints.内分泌干扰化学物质与疾病终点
Int J Mol Sci. 2023 Mar 10;24(6):5342. doi: 10.3390/ijms24065342.
9
The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.避孕药和绝经激素治疗中使用的孕激素通过孕激素受体 A 的转录活性取决于受体的密度。
Biochem Biophys Res Commun. 2023 Jan 8;639:70-76. doi: 10.1016/j.bbrc.2022.11.077. Epub 2022 Nov 26.
10
The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy.卵巢甾体激素在腔 A 型乳腺癌 MCF-7 模型中的多效性作用:治疗的机制线索。
Int J Mol Sci. 2022 Apr 27;23(9):4800. doi: 10.3390/ijms23094800.